In addition, higher endogenous fasting GLP-1 levels were found to be associated with lower risk of any incident first cancer, whereas both fasting glucose and GIP-levels were marginally significantly associated with increased risk of incident cancer risk when adjusted for age and sex. This evidence concerns the gene GLP1R and cancer.